Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 2 |
Search Results
2 results
Results by year
Page 1
Exploring Predictive Risk Factors of Infusion Reactions with First Pertuzumab Administration in HER2-positive Breast Cancer Patients: A Single Institution Experience.
JMA J. 2023 Jan 16;6(1):63-72. doi: 10.31662/jmaj.2022-0132. Epub 2022 Dec 23.
JMA J. 2023.
PMID: 36793527
Free PMC article.
Incidence and risk factors of infusion reactions in patients with breast cancer administered trastuzumab plus pertuzumab-based regimen.
Tabuchi Y, Tsujimoto M, Yamamoto K, Kosaka T, Sakaguchi K, Dobuchi N, Nishiguchi K, Shikata K.
Tabuchi Y, et al.
Cancer Chemother Pharmacol. 2023 Jan;91(1):25-31. doi: 10.1007/s00280-022-04492-6. Epub 2022 Nov 19.
Cancer Chemother Pharmacol. 2023.
PMID: 36401659
Item in Clipboard
Cite
Cite